Alex Wilson
Director of Corporate Development & Quality @Novai
Signup · Get unlimited contacts
WORK HISTORY
Director of Corporate Development & Quality @Novai
England, GB
EDUCATION
The University of Chicago Booth School of Business
Master of Business Administration (M.B.A.), Business Administration and Management, General
University of Bradford
PhD, Psycopharmacology
University of Bradford
BSc, Biomedical Science (Pharmacology & Toxicology) [1st Class hons]
ABOUT ALEX WILSON
1st class (Hons) Degree in Biomedical Sciences, PhD Psychopharmacology of substance abuse,(Bradford University, 1993 & 1996). Executive MBA, 2016, University of Chicago Booth School of Business.Post-doc (19••••98), Hammersmith Hospital, London, Parkinson’s Disease.SmithKline Beecham, UK Neuroscience pharmacodynamic modelling.GlaxoSmithKline, UK Neurology, Pain and Epilepsy. Particularly well versed in Lead Optimisation programmes & project development.Maccine Pte Ltd, Singapore (20••••14). Department Head, CSO, COO & CEO.GLP CRO with a portfolio of non-human primate translation models & Safety Assessment in multiple species. SERI/IMCB Programme of Retinal Angiogenic Diseases, 20••••15. DirectorSIPRAD’s mission was to develop an industry-standard research platform in retinal angiogenic diseases that leverages the complementary expertise of SERI (Singapore Eye Research Institute) & IMCB in clinical and preclinical science to identify and validate novel biomarkers and targets, and evaluate potential anti-angiogenic therapeutics in partnership with the pharmaceutical industry.Apta Biosciences Pte Ltd,(20••••18)Managing DirectorApta is a synthetic biology company specialised in developing unique, proprietary affinity molecules that can be used broadly across diagnostics & therapeutics to facilitate and expand scientific discovery enabling the development of new healthcare solutions.Neuro-Bio Ltd,(2019-present)Chief Operating OfficerNeuro-Bio Ltd is an SME biotech spin-out from the University of Oxford, leveraging decades of academic excellence from the labs of Baroness Professor Susan Greenfield. My role is to design and enable implementation of a programme of activities supporting pivotal submissions to regulatory bodies for approval of both an in vitro diagnostic test as well as a therapy for Alzheimer’s Disease, that would change the face of geriatric medicine and quality of lives of an ever ageing population!
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.